Teva to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 04 2018 - 11:12AM
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a
live audio webcast at the 36th Annual J.P. Morgan Healthcare
Conference. Kåre Schultz, President & CEO will present on
Monday, January 8, 2018 at 9:30 AM PST.
What:
Teva Presentation at the 36th Annual J.P. Morgan Healthcare
Conference
Who:
Kåre Schultz, President & CEO Teva Pharmaceutical Industries
Ltd.
When:
Monday, January 8, 2018 at 9:30 AM PST
Where:
www.ir.tevapharm.com
How:
Live over the Internet – log on to the Web at the address above and
register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a
leading global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions used by approximately 200
million patients in over 60 markets every day. Headquartered in
Israel, Teva is the world’s largest generic medicines producer,
leveraging its portfolio of more than 1,800 molecules to produce a
wide range of generic products in nearly every therapeutic area. In
specialty medicines, Teva has the world-leading innovative
treatment for multiple sclerosis as well as late-stage development
programs for other disorders of the central nervous system,
including movement disorders, migraine, pain and neurodegenerative
conditions, as well as a broad portfolio of respiratory products.
Teva is leveraging its generics and specialty capabilities in order
to seek new ways of addressing unmet patient needs by combining
drug development with devices, services and technologies. Teva’s
net revenues in 2016 were $21.9 billion. For more information,
visit www.tevapharm.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180104005883/en/
Teva Pharmaceutical Industries Ltd.IR:United States:Kevin C.
Mannix, 215-591-8912orIsrael:Ran Meir, 972 (3)
926-7516orIsrael:Tomer Amitai, 972 (3) 926-7656orPR:Israel:Iris
Beck Codner, 972 (3) 926-7208orUnited States:Denise Bradley,
215-591-8974
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Sep 2023 to Sep 2024